Related Experiment Video
Updated: Sep 13, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Anaemia, cardiovascular disease and kidney disease: integrating new knowledge in 2002
Lesley A Stevens1, Adeera Levin
1University of British Columbia, Vancouver, Canada.
Insights
Cardiovascular disease (CVD) in chronic kidney disease (CKD) patients is complex. While anaemia is linked to CVD, its direct causal role is unclear, necessitating personalized treatment and further research.
Area of Science:
- Nephrology
- Cardiology
- Hematology
Background:
- Chronic kidney disease (CKD) is frequently associated with anemia.
- Anemia and cardiovascular disease (CVD) are common comorbidities in CKD patients.
- The interplay between anemia and CVD in CKD is complex and not fully understood.
Purpose of the Study:
- To review recent literature (2001-present) on the relationship between CVD and anemia in CKD patients.
- To synthesize findings from basic science and clinical studies.
- To understand the impact of hemoglobin levels on survival in CKD.
Main Methods:
- Literature review of publications from 2001 to the present.
- Analysis of basic science literature regarding erythropoietin and its receptors.
- Examination of observational and interventional clinical studies.
Main Results:
- Recent basic science research provides context for clinical findings on hemoglobin and survival in CKD.
- The effects of erythropoietin and its receptors in various tissues are described.
- Limitations in clinical study methodologies are highlighted.
Conclusions:
- CVD development in CKD patients is multifactorial.
- The direct causal link between anemia and CVD in CKD is difficult to establish due to shared risk factors.
- Prevention of anemia and individualized treatment goals are crucial.
- Well-designed prospective studies are needed to determine optimal therapeutic strategies.
Purpose Of Review:
The present review assesses recent publications, from 2001 until the present, which address the relationship between cardiovascular disease (CVD) and anaemia in patients with chronic kidney disease.
Recent Findings:
Insights from the recently published basic science literature have helped to place findings from clinical studies into a new context, and thereby assist us to understand and further explore the complex relationship between haemoglobin level and survival in chronic kidney disease. The effects of erythropoietin molecules and the presence of receptors in vascular endothelium, myocardium and other tissues are described. Both observational and interventional clinical studies are examined, and limitations in the methodology and statistical analysis of clinical studies are emphasized, but are given context within the body of literature preceding the past year's publications.
Summary:
Data suggest that development of CVD in patients with kidney disease is multifactorial. Several factors associated with CVD are also associated with anaemia, thereby making causal arguments for the role of anaemia in CVD and survival difficult. Arguments are made for the importance of prevention of anaemia and of individualizing therapeutic goals for its treatment. Well designed prospective studies with both CVD events and mortality as outcomes, and with enrollment beginning before the start of dialysis, are essential if we are to determine the optimal therapeutic strategies.
Related Concept Videos
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management

